Document:

Form of Restricted Stock Agreement

 Exhibit 10.3 

CURIS, INC. 

Restricted Stock Agreement 
  

					
	Name of Recipient:	  	  
	  	
			
	Number of shares of restricted common stock awarded:	  	  
	  	
			
	Grant Date:	  	  
	  	

 Curis, Inc. (the “Company”) has selected you to receive the restricted stock award
described above, which is subject to the provisions of the Company’s 2010 Stock Incentive Plan (the “Plan”) and the terms and conditions contained in this Restricted Stock Agreement. Please confirm your acceptance of this restricted
stock award and of the terms and conditions of this Agreement by signing a copy of this Agreement where indicated below. 
  

			
	Curis, Inc.
		
	By:	 	  

		 	[insert name and title]

  

	
	Accepted and Agreed:
	
	  

	[insert name of recipient]

 CURIS, INC. 

Restricted Stock Agreement 

The terms and conditions of the award of shares of restricted common stock of the Company (the “Restricted Shares”) made to the
Recipient, as set forth on the cover page of this Agreement, are as follows: 
 1. Issuance of Restricted Shares.

 (a) The Restricted Shares are issued to the Recipient, effective as of the Grant Date (as set forth on the cover page of this
Agreement), in consideration of employment services rendered and to be rendered by the Recipient to the Company. 
 (b) The
Restricted Shares will initially be issued by the Company in book entry form only, in the name of the Recipient. Following the vesting of any Restricted Shares pursuant to Section 2 below, the Company shall, if requested by the Recipient, issue
and deliver to the Recipient a certificate representing the vested Restricted Shares. The Recipient agrees that the Restricted Shares shall be subject to the forfeiture provisions set forth in Section 3 of this Agreement and the restrictions on
transfer set forth in Section 4 of this Agreement. 
 2. Vesting. 

(a) Vesting Schedule. Unless otherwise provided in this Agreement or the Plan, the Restricted Shares shall vest in accordance with
the following vesting schedule:
                                         
                                       .

 3. Forfeiture of Unvested Restricted Shares Upon Employment Termination. 

In the event that the Recipient ceases to be employed by the Company for any reason or no reason, with or without cause, all of the
Restricted Shares that are unvested as of the time of such employment termination shall be forfeited immediately and automatically to the Company, without the payment of any consideration to the Recipient, effective as of such termination of
employment. The Recipient shall have no further rights with respect to any Restricted Shares that are so forfeited. If the Recipient is employed by a subsidiary of the Company, any references in this Agreement to employment with the Company shall
instead be deemed to refer to employment with such subsidiary. 
 4. Restrictions on Transfer. 

The Recipient shall not sell, assign, transfer, pledge, hypothecate or otherwise dispose of, by operation of law or otherwise
(collectively “transfer”) any Restricted Shares, or any interest therein, until such Restricted Shares have vested, except that the Recipient may transfer such Restricted Shares: (a) to or for the benefit of any spouse, children,
parents, uncles, aunts, siblings, grandchildren and any other relatives approved by the Compensation Committee (collectively, “Approved Relatives”) or to a trust established solely for the benefit of the

 
Recipient and/or Approved Relatives, provided that such Restricted Shares shall remain subject to this Agreement (including without limitation the forfeiture provisions set forth in
Section 3 and the restrictions on transfer set forth in this Section 4) and such permitted transferee shall, as a condition to such transfer, deliver to the Company a written instrument confirming that such transferee shall be bound by all
of the terms and conditions of this Agreement; or (b) as part of the sale of all or substantially all of the shares of capital stock of the Company (including pursuant to a merger or consolidation). The Company shall not be required (i) to
transfer on its books any of the Restricted Shares which have been transferred in violation of any of the provisions of this Agreement or (ii) to treat as owner of such Restricted Shares or to pay dividends to any transferee to whom such
Restricted Shares have been transferred in violation of any of the provisions of this Agreement. 
 5. Restrictive
Legends. 
 The book entry account reflecting the issuance of the Restricted Shares in the name of the Recipient shall bear
a legend or other notation upon substantially the following terms: 
 “These shares of stock are subject to forfeiture
provisions and restrictions on transfer set forth in a certain Restricted Stock Agreement between the corporation and the registered owner of these shares (or his or her predecessor in interest), and such Agreement is available for inspection
without charge at the office of the Secretary of the corporation.” 
 6. Rights as a Shareholder. 

Except as otherwise provided in this Agreement, for so long as the Recipient is the registered owner of the Restricted Shares, the
Recipient shall have all rights as a shareholder with respect to the Restricted Shares, whether vested or unvested, including, without limitation, rights to vote the Restricted Shares and act in respect of the Restricted Shares at any meeting of
shareholders; provided that, as provided in the Plan, the payment of dividends on unvested Restricted Shares shall be deferred until after such shares vest. 

7. Provisions of the Plan. 

This Agreement is subject to the provisions of the Plan, a copy of which is furnished to the Recipient with this Agreement. 

8. Tax Matters. 

(a) Acknowledgments; Section 83(b) Election. The Recipient acknowledges that he or she is responsible for obtaining the
advice of the Recipient’s own tax advisors with respect to the acquisition of the Restricted Shares and the Recipient is relying solely on such advisors and not on any statements or representations of the Company or any of its agents with
respect to the tax consequences relating to the Restricted Shares. The Recipient understands that the Recipient (and not the Company) shall be responsible for the Recipient’s tax liability that may arise in connection with the acquisition,
vesting and/or disposition of the Restricted Shares. The Recipient acknowledges that he or she has been informed of the availability of making an election under Section 83(b) of the Internal Revenue Code, as amended, with respect to the
issuance of the Restricted Shares[ and that the Recipient has decided not to file a Section 83(b) 

 
election.] [The Recipient agrees that he or she will deliver written notice to the Company if he or she files a Section 83(b) election and he or she will provide for the tax withholding
obligations that would apply if such an election is made.] 
 (b) Withholding. The Recipient acknowledges and agrees that
the Company has the right to deduct from payments of any kind otherwise due to the Recipient any federal, state, local or other taxes of any kind required by law to be withheld with respect to the vesting of the Restricted Shares. On each date on
which Restricted Shares vest, the Company shall deliver written notice to the Recipient of the amount of withholding taxes due with respect to the vesting of the Restricted Shares that vest on such date; provided, however, that the total tax
withholding cannot exceed the Company’s minimum statutory withholding obligations (based on minimum statutory withholding rates for federal and state tax purposes, including payroll taxes, that are applicable to such supplemental taxable
income). The Recipient shall satisfy such tax withholding obligations by making a cash payment to the Company on the date of vesting of the Restricted Shares, in the amount of the Company’s withholding obligation in connection with the vesting
of such Restricted Shares. 
 9. Miscellaneous. 

(a) Authority of Committee. In making any decisions or taking any actions with respect to the matters covered by this Agreement,
the Committee (as defined in the Plan) shall have all of the authority and discretion, and shall be subject to all of the protections, provided for in the Plan. All decisions and actions by the Committee with respect to this Agreement shall be made
in the Committee’s discretion and shall be final and binding on the Recipient. 
 (b) No Right to Continued
Employment. The Recipient acknowledges and agrees that, notwithstanding the fact that the vesting of the Restricted Shares is contingent upon his or her continued employment by the Company, this Agreement does not constitute an express or
implied promise of continued employment or confer upon the Recipient any rights with respect to continued employment by the Company. 

(c) Governing Law. This Agreement shall be construed, interpreted and enforced in accordance with the internal laws of the State
of Delaware without regard to any applicable conflicts of laws provisions. 
 (d) Recipient’s Acknowledgments. The
Recipient acknowledges that he or she has read this Agreement, has received and read the Plan, and understands the terms and conditions of this Agreement and the Plan.Offer Letter between the Company and Mitchell Keegan

 Exhibit 10.4 

March 21, 2008 
 Dr. Mitchell Keegan

 [                    ] 

[                    ] 

Dear Mitch: 
 I am pleased to confirm our offer
to you for the position at Curis, Inc. The terms of our offer for your employment with the Company are outlined below. 
 Position: Executive
Director, Drug Development 
 Description of Duties: You will be responsible for oversight of all development aspects of Curis’
proprietary drug programs, particularly from lead clinical candidate selection through clinical testing. 
 Reporting to: Michael Gray,
CFO & COO 
 Employment Date: Your starting date will be on or about April 23, 2008, or any other mutually agreeable date.

 Work Week: You will generally work Monday through Friday, at least 40 hours per week. 

Rate of Pay: $18,750.00 per month to be reviewed as part of our performance review program. It is understood that paychecks will be issued on
alternating Fridays. 
 Your rate of pay and title will be reviewed no later than December 2008, in accordance with company policies. You will
additionally be eligible for a discretionary bonus, in accordance with company procedures, or in the future, in accordance with a formal executive officer bonus program, which is currently being evaluated by our compensation committee. 

As discussed, at such time it is agreed upon that you are promoted to the level of Vice President, you will be documented as a named officer of the
Company, and will at that time be asked to sign an employment agreement outlining your severance terms and any outcomes resulting from a change of control of Curis. 

 Mitchell Keegan 

 Page
 2
 
  

 Benefits: You will be eligible to participate in the Curis employee benefit program as of your
date of hire or in accordance with plan provisions. This comprehensive program currently includes medical and dental benefits, life and disability insurances, and a Section 125 Plan. You will be eligible to participate in our 401(k) Plan upon
your date of hire. You will accrue three weeks of vacation during your first year of employment and are subject to the terms for accrual and use. Parking is provided, or the cost of a MBTA pass is reimbursed in accordance with usual Company
practice. Curis also offers an Employee Stock Purchase Plan with entry dates of December and June after completing six months of employment. Employee benefits may be changed from time to time at the sole discretion of Curis. If you need additional
information or have questions, please feel free to contact Rachel Blasbalg at (617) 503-6542. 
 Stock Options: We will recommend to
our compensation committee that you receive a stock option to purchase 150,000 shares of Curis common stock, to be awarded by the compensation committee of the board of directors with effect from the date of the compensation committee’s
approval. The next compensation committee meeting is scheduled for April 4, 2008. The shares will be awarded at the last trade price on the NASDAQ on the day of approval and will vest over four years, 25% after the first year and 6.25% per
quarter over the remainder of the vesting period. Vesting of stock options is contingent upon your continued employment at Curis. The award will be subject to and governed by the terms and conditions of an agreement between you and the Curis and the
Curis Inc. 2000 Stock Incentive Plan (the “Plan”). A copy of the Plan is included in with this letter for your review. 
 It should be
understood by you that your employment at Curis, Inc. is at all times on an “at will” basis, which means that it is not guaranteed for any specified period of time and may be terminated by you or by Curis at any time, with or without
notice, and regardless of the date of payment of your salary. By accepting employment with Curis, you acknowledge and agree that no contrary representation has been made to you. This at-will employment relationship will remain in effect throughout
your employment with Curis. It may not be modified by an oral or implied agreement. The terms of your employment will be interpreted in accordance with and governed by the laws of The Commonwealth of Massachusetts. 

In the event your employment is involuntarily terminated with the Company without cause, the Company will continue to pay you as severance benefits your
base salary as in effect on the date of your termination and provide you with any other benefits owed to you by virtue of your employment with the Company, to the extent that such benefits can be provided to non-employees, for four months. Cause
means (a) a good faith finding by the Company of dishonesty, gross negligence, or misconduct, (b) conviction or the entry of a pleading of guilty or nolo contender e to any crime or any felony, or (c) any breach or threatened
breach of any confidentiality, non-competition, non-solicitation, or inventions agreement with the Company. 
  

 2 

 Mitchell Keegan 

 Page
 3
 
  

 This offer is premised on your representation that you are not subject to any confidentiality or
non-competition agreement or any other similar type of restriction that would affect your ability to devote your full time and attention to your work at Curis, Inc. The offer is also contingent upon your signing the enclosed Invention,
Non-Disclosure and Non-Competition Agreement. You will also be required to present documentation prior to starting work with the Company that verifies your identity and authorization to work in the U.S., in accordance with the Immigration Reform
and Control Act of 1986. 
 Please note that our offer of employment, including your stock option award, is contingent upon the results of your
background check. 
 If the terms of this offer are acceptable, please indicate your acceptance by signing both copies of this letter and the
Invention, Non-Disclosure and Non-competition Agreement included with this letter. Please return one copy of each to Rachel Blasbalg, Human Resources by Tuesday, March 25, 2008. 

We are extremely enthusiastic about the prospect of working with you at Curis. We believe that Curis will offer an outstanding opportunity for you to
achieve both your personal and professional goals in an exciting scientific and business environment. We feel you will be a great addition to our team. 
  

	
	Sincerely,
	
	 /s/ Rachel S. Blasbalg

	Rachel S. Blasbalg
	Manager, Human Resources

 Agreed and accepted: 

 

	
	 /s/ Mitch Keegan

	Mitchell Keegan

 Date: March 24, 2008 

Enclosures 
 Invention,
Non-Disclosure and Non-Competition Agreement 
  

 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00174-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00174-of-00352.parquet"}]]